References
- Araki M., Nanri H., Ejima K., Murasato Y., Fujiwara T., Nakashima Y., Ikeda M. “Antioxidant function of the mitochondrial protein SP-22 in the cardiovascular system”. J. Biol. Chem. 1999; 274: 2271–2278
- Baker A., Payne C. M., Briehl M. M., Powis G. “Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vivo and in vitro”. Cancer Res. 1997; 57: 5162–5167
- Bennett C. F., Balcarek J. M., Varrichio A., Crooke S. T. “Molecular cloning and complete amino-acid sequence of form-I phosphoinositide-specific phospholipase C”. Nature 1988; 334: 268–270
- Breathnach R., Chambon P. “Organisation and expression of eukaryotic split genes coding for proteins”. Annu. Rev. Biochem. 1981; 50: 349–383
- Eklund H., Gleason F. K., Holmgren A. “Structural and functional relations among thioredoxins of different species”. Proteins: Structure, function and Genetics 1991; 11: 13–28
- Eppert K., Scherer S., Ozcelik H., Pirone R., Hoodless P., Kim H., Tsui L., Bapat B., Gallinger S., Andrulis I., Thomsen G., Wrana J., Attisano L. “MADR2 maps to 18q21 and encodes a TGFbeta-reguiated MAD-related protein that is functionally mutated in colorectal carcinoma”. Cell 1996; 86: 542–552
- Fullekrug J., Sonnichsen B., Wunsch U., Arseven K., Van Nguyen P., Soling H. D., Mieskes G. “CaBPl, a calcium binding protein of the thioredoxin family, is a resident KDEL protein of the ER and not of the intermediate compartment”. J. Cell Biol 1994; 107: 2719–2727
- Gallegos A., Gasdaska J., Taylor C., Paine-Murrieta G., Goodman D., Gasdaska P., Berggren M., Briehl M., Powis G. “Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells”. Cancer Res. 1996; 56: 5765–5770
- Holmgren A. “Thioredoxin”. Annu. Rev. Biochem. 1985; 54: 237–271
- Kemmink J., Darby N. J., Dijkstra K., Nilges M., Creighton T. E. “The folding catalyst protein disulfide isomerase is constructed of active and inactive thioredoxin modules”. Current Biol. 1997; 7: 239–245
- Kurooka H., Kato K., Minoguchi S., Takahashi Y., Ikeda J. E., Habu S., Osawa N., Buchberg A. M., Moriwaki K., Shisa H., Honjo T. “Cloning and characterization of the nucleoredoxin gene that encodes a novel nuclear protein related to thioredoxin. Genomics 1997; 39: 331–339
- Lee K. K., Murakawa M., Takahashi S., Tsubuki S., Kawashima S., Sakamaki K., Yonehara S. “Purification, molecular cloning and characterization of TRP32, a novel thioredoxin-related mammalian protein of 32 kDa”. J. Biol. Chem. 1998; 273: 19160–19166
- Miranda-Vizuete A., Gustafsson J. Å., Spyrou G. “Molecular cloning and expression of a cDNA encoding a human thioredoxin-like protein”. Biochem. Biophys. Res. Commun. 1998; 243: 284–288
- Ohno H., Fukuhara S., Takahashi R., Mihara K., Sugiyama T., Doi S., Uchino H., Toyoshima K. “c-yes and bcl-2 genes located on 18q21.3 in a follicular lymphoma cell line carrying a t(14;18) chromosomal translocation”. Int. J. Cancer 1987; 39: 785–788
- Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawataba M., Miyazono K., Ichijo H. “Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1”. EMBO J. 1998; 17: 2596–2606
- Spyrou G., Enmark E., Miranda-Vizuete A., Gustafsson J. Å. “Cloning and expression of a novel mammalian thioredoxin”. J. Biol. Chem. 1997; 272: 2936–2941
- Tonissen K. F., Wells J. R.E. “Isolation and characterization of human thioredoxin-encoding genes”. Gene 1991; 102: 221–228
- Uchida K., Nagatake M., Osada H., Yatabe Y., Kondo M., Mitsudomi T., Masuda A., Takahashi T. “Somatic in vivo alterations of the JV18–1 gene at 18q21 in human lung cancers”. Cancer Res. 1996; 56: 5583–5585
- Ueda T., Komiya A., Emi M., Suzuki H., Shiraishi T., Yatani R., Masai M., Yasuda K., Ito H. “Allelic loses on 18q21 are associated with progression and metastasis in human prostate cancer”. Genes, Chrom. Can. 1997; 20: 140–147